National Drug Code (NDC) Database
-
NDC:
11737-600
-
Nonproprietary Name:
Calcium Carbonate
-
Dosage Form:
POWDER
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
0.9 kg/kg
-
Substance:
CALCIUM CARBONATE
-
Start Marketing Date:
2005-01-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Patheon API Manufacturing, Inc.
-
NDC:
64274-9001
-
Nonproprietary Name:
Metaraminol Bitartrate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
METARAMINOL BITARTRATE
-
Start Marketing Date:
2021-02-08
-
End Marketing Date:
2026-11-09
-
DEA Schedule:
-
Certified Through:
0000-00-00
Patheon API, Inc
-
NDC:
63482-801
-
Nonproprietary Name:
Mirdametinib
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
MIRDAMETINIB
-
Start Marketing Date:
2025-02-11
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Patheon API, Inc.
-
NDC:
63482-802
-
Nonproprietary Name:
Sotorasib
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
SOTORASIB
-
Start Marketing Date:
2021-05-28
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Patheon Austria GmbH & CoKG
-
NDC:
45941-3057
-
Nonproprietary Name:
Opicapone
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
OPICAPONE
-
Start Marketing Date:
2020-04-24
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Patheon Biologics B.V.
-
NDC:
83266-0000
-
Nonproprietary Name:
NAXITAMAB
-
Dosage Form:
SOLUTION, CONCENTRATE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
4 g/L
-
Substance:
NAXITAMAB
-
Start Marketing Date:
2020-02-08
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Patheon Biologics LLC
-
NDC:
67920-1006
-
Nonproprietary Name:
lerodalcibep-liga
-
Dosage Form:
INJECTION, SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
300 mg/1.2mL
-
Substance:
LERODALCIBEP
-
Start Marketing Date:
2026-06-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
PATHEON FRANCE S.A.S
-
NDC:
47049-043
-
Nonproprietary Name:
Adagrasib
-
Dosage Form:
TABLET, COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
200 mg/1
-
Substance:
ADAGRASIB
-
Start Marketing Date:
2024-12-02
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Patheon France S.A.S.
-
NDC:
47049-056
-
Nonproprietary Name:
mavacamten
-
Dosage Form:
CAPSULE, GELATIN COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
15 mg/1
-
Substance:
MAVACAMTEN
-
Start Marketing Date:
2026-05-11
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Patheon Italia S.p.A.
-
NDC:
68225-258
-
Nonproprietary Name:
mogamulizumab-kpkc
-
Dosage Form:
INJECTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
4 mg/mL
-
Substance:
MOGAMULIZUMAB
-
Start Marketing Date:
2024-10-26
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.